Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Screening for plasma uric acid is widespread in many countries including Italy. This is based on the assumption that alongside gout, hyperuricemia may be associated with and contribute to several cardiovascular, renal, and metabolic disorders, although evidence of the clinical utility of such routine screening is still scant.1
An 81-year-old woman was found to have serum uric acid and creatinine concentrations of 6.6 mg/dL and 2.31 mg/dL, repectively (to convert to micromoles per liter, multiply by 59.485 for uric acid and by 88.4 for creatinine), on a routine screening test. The clinical examination revealed no major health problems and no history or examination findings suggestive of gout. She received a diagnosis of asymptomatic hyperuricemia, for which she was treated with 150 mg/d of allopurinol. Immediately after the first administration of allopurinol, the patient developed a severe hypersensitivity reaction, her clinical condition worsened significantly, and despite treatments she died a few days after admission to the hospital.
Carnovale C, Venegoni M, Clementi E. Allopurinol Overuse in Asymptomatic Hyperuricemia: A Teachable Moment. JAMA Intern Med. 2014;174(7):1031–1032. doi:10.1001/jamainternmed.2014.1427
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: